Power of Rhetoric: How Corporate Rhetorical Nationalism Reshapes Institutional Investment Choices?
International Journal of Finance & Economics · 06.07.2026
DOI: 10.1002/ijfe.70254 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Finance & Economics, online erschienen am 06.07.2026. Verfasst von Jinhai Wang und 2 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
A growing body of research shows that firms are making increasing use of rhetorical nationalism. Using 2007–2024 China A‐share data, we examine how corporate rhetorical nationalism affects institutional investors' stock preferences. Results show rhetorical nationalism significantly increases overall institutional holdings, particularly among long‐term investors. Rhetoric about territorial sovereignty and national renewal strongly boosts institutional holdings, while anti‐foreign themes have a limited effect. Using institutional theory, we find rhetorical nationalism works through two channels: helping firms get resources and reducing risks. However, corporate nationalist rhetoric also pushes foreign investors away, which may hurt China's global trade integration. Our findings suggest investors should consider local culture in their strategies. Policymakers need to balance openness with national identity.
Zitieren
APA
Wang, J., Jin, T., & Liang, X. (2026). Power of Rhetoric: How Corporate Rhetorical Nationalism Reshapes Institutional Investment Choices?. International Journal of Finance & Economics. https://doi.org/10.1002/ijfe.70254
Vancouver
Wang J, Jin T, Liang X. Power of Rhetoric: How Corporate Rhetorical Nationalism Reshapes Institutional Investment Choices?. International Journal of Finance & Economics. 2026. doi:10.1002/ijfe.70254
BibTeX
@article{Wang2026,
author = {Wang, Jinhai and Jin, Tianquan and Liang, Xinye},
title = {Power of Rhetoric: How Corporate Rhetorical Nationalism Reshapes Institutional Investment Choices?},
journal = {International Journal of Finance & Economics},
year = {2026},
doi = {10.1002/ijfe.70254}
}
EUVIMED